ATE71663T1 - Blutplaettchenaktivitaetssupprimierendes lymphokin, verfahren zu seiner isolierung und reinigung, und dieses enthaltendes arzneimittel. - Google Patents
Blutplaettchenaktivitaetssupprimierendes lymphokin, verfahren zu seiner isolierung und reinigung, und dieses enthaltendes arzneimittel.Info
- Publication number
- ATE71663T1 ATE71663T1 AT87401122T AT87401122T ATE71663T1 AT E71663 T1 ATE71663 T1 AT E71663T1 AT 87401122 T AT87401122 T AT 87401122T AT 87401122 T AT87401122 T AT 87401122T AT E71663 T1 ATE71663 T1 AT E71663T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- ige
- isolation
- purification
- lymphocine
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 238000002955 isolation Methods 0.000 title abstract 2
- 238000000746 purification Methods 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 210000001772 blood platelet Anatomy 0.000 abstract 2
- 230000001419 dependent effect Effects 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 230000010118 platelet activation Effects 0.000 abstract 2
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 241000242680 Schistosoma mansoni Species 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 230000002141 anti-parasite Effects 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000003013 cytotoxicity Effects 0.000 abstract 1
- 231100000135 cytotoxicity Toxicity 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 230000002584 immunomodulator Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8607194A FR2598917B1 (fr) | 1986-05-21 | 1986-05-21 | Nouvelle lymphokine suppressive de l'activation plaquettaire, son procede d'isolement et de purification et medicaments la contenant |
| EP87401122A EP0246967B1 (de) | 1986-05-21 | 1987-05-19 | Blutplättchenaktivitätssupprimierendes Lymphokin, Verfahren zu seiner Isolierung und Reinigung, und dieses enthaltendes Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE71663T1 true ATE71663T1 (de) | 1992-02-15 |
Family
ID=9335417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87401122T ATE71663T1 (de) | 1986-05-21 | 1987-05-19 | Blutplaettchenaktivitaetssupprimierendes lymphokin, verfahren zu seiner isolierung und reinigung, und dieses enthaltendes arzneimittel. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5071959A (de) |
| EP (1) | EP0246967B1 (de) |
| JP (1) | JPH01501597A (de) |
| AT (1) | ATE71663T1 (de) |
| AU (1) | AU608758B2 (de) |
| DE (1) | DE3775982D1 (de) |
| DK (1) | DK25488D0 (de) |
| FR (1) | FR2598917B1 (de) |
| GR (1) | GR3004289T3 (de) |
| PT (1) | PT84913B (de) |
| WO (1) | WO1987007303A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5236705A (en) * | 1989-01-20 | 1993-08-17 | The University Of Melbourne | Fibrinolysis |
| JPH07118168A (ja) * | 1993-10-19 | 1995-05-09 | Tomoyasu Ra | ＩｇＥ産生抑制剤 |
| US5874404A (en) * | 1992-08-04 | 1999-02-23 | Chisei Ra | Immunoglobulin E receptor α-chain inhibits IgE production and secondary allergic responses |
| US5451660A (en) * | 1993-12-13 | 1995-09-19 | Genentech, Inc. | Method for purifying polypeptides |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60502202A (ja) * | 1983-08-18 | 1985-12-19 | クイデル | アレルギ−抑制因子 |
-
1986
- 1986-05-21 FR FR8607194A patent/FR2598917B1/fr not_active Expired
-
1987
- 1987-05-19 DE DE8787401122T patent/DE3775982D1/de not_active Expired - Lifetime
- 1987-05-19 WO PCT/FR1987/000164 patent/WO1987007303A1/fr not_active Ceased
- 1987-05-19 AU AU74321/87A patent/AU608758B2/en not_active Ceased
- 1987-05-19 JP JP62503079A patent/JPH01501597A/ja active Pending
- 1987-05-19 AT AT87401122T patent/ATE71663T1/de not_active IP Right Cessation
- 1987-05-19 US US07/168,009 patent/US5071959A/en not_active Expired - Fee Related
- 1987-05-19 EP EP87401122A patent/EP0246967B1/de not_active Expired - Lifetime
- 1987-05-20 PT PT84913A patent/PT84913B/pt not_active IP Right Cessation
-
1988
- 1988-01-20 DK DK025488A patent/DK25488D0/da not_active Application Discontinuation
-
1992
- 1992-04-08 GR GR920400644T patent/GR3004289T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU608758B2 (en) | 1991-04-18 |
| DK25488A (da) | 1988-01-20 |
| PT84913B (pt) | 1990-02-08 |
| FR2598917A1 (fr) | 1987-11-27 |
| FR2598917B1 (fr) | 1988-08-19 |
| WO1987007303A1 (fr) | 1987-12-03 |
| GR3004289T3 (de) | 1993-03-31 |
| DK25488D0 (da) | 1988-01-20 |
| EP0246967A1 (de) | 1987-11-25 |
| US5071959A (en) | 1991-12-10 |
| DE3775982D1 (de) | 1992-02-27 |
| PT84913A (fr) | 1987-06-01 |
| JPH01501597A (ja) | 1989-06-08 |
| AU7432187A (en) | 1987-12-22 |
| EP0246967B1 (de) | 1992-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE15798T1 (de) | Heterozyklische carboxamide, zubereitungen, die solche verbindungen enthalten, verfahren zu ihrer herstellung und methoden zur behandlung damit. | |
| RU95113967A (ru) | Амино-замещенные пиразолы, композиция, обладающая crf антагонистической активностью, способ лечения, промежуточный продукт | |
| ES2154270T3 (es) | Nuevos derivados del imidazol, su preparacion y sus aplicaciones terapeuticas. | |
| UA29421C2 (uk) | Спосіб виділення фактора vііі з інших білків в плазмі крові | |
| ATE103915T1 (de) | Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel. | |
| ATE53003T1 (de) | Substituierte acrylsaeureester und fungizide, die diese verbindungen enthalten. | |
| ATE96807T1 (de) | Rcrf und aehnliche verbindungen. | |
| ATE232394T1 (de) | Verwendung von modifiziertem c-reaktiven protein zur herstellung eines medikaments zur behandlung von krebs | |
| ATE79392T1 (de) | Verfahren fuer eine verbesserte verbrennung in verbrennungsprozessen, die kohlenwasserstoffe verwenden. | |
| ATE34985T1 (de) | 1,7-diamino-1,4-dihydro-4-oxo-3-(aza) chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung bakterieller erkrankungen. | |
| DE68905283D1 (de) | Alpha,alpha disubstituierte n-cycloalkylalkyl-benzylamine, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und ihre zwischenprodukte bei der herstellung. | |
| ATE71663T1 (de) | Blutplaettchenaktivitaetssupprimierendes lymphokin, verfahren zu seiner isolierung und reinigung, und dieses enthaltendes arzneimittel. | |
| ES2039408T3 (es) | Un procedimiento para preparar un compuesto de tienotriazolodiazepina. | |
| DE59002154D1 (de) | Kombinationspraeparate enthaltend rifampicin und thioacetazon sowie gegebenenfalls isonicotinsaeurehydrazid oder ethambutol als aktive wirkstoffe. | |
| ATE25849T1 (de) | Tricyclophosphazen-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ATE27157T1 (de) | Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| EP1320351A4 (de) | Methoden der zubereitung von immunglobulin und dessen verwendungen | |
| PT68483A (de) | N-substituierte 2-hydrazono-propionsaure-derivate verfahren zur herstellung derselben und arzneimittel die diese enthalten | |
| ATE182588T1 (de) | Verfahen zur herstellung von (s)(+)-4, 4'-(1- methyl-1,2-ethandiyl)-bis(2,6-piperazindion | |
| DE3778642D1 (de) | Therapeutikum zur behandlung von magengeschwueren. | |
| PT81702A (de) | N-substituierte aziridin-2-carbonsauerederivate verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel | |
| DE68902668D1 (de) | Verfahren zur thermischen behandlung von galliumarsenid-einkristallen. | |
| CA2512713A1 (en) | Bicyclic carbohydrate compounds useful in the treatment of infections caused by flaviviridae sp., such as hepatitis c and bovine viral diarrhea viruses | |
| ATE137752T1 (de) | 5-aminocarbonyl-5h-dibenzo-a,d>cyclohepten-5,10 imine zur behandlung von epilepsie und kokainsucht | |
| ATE279521T1 (de) | Regulierende nukleinsaeuresequenzen und verwendungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |